RecruitingNot Applicable

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

United States500 participantsStarted 2019-10-08

Plain-language summary

The purpose of this research is to study the natural history of congenital disorders of glycosylation and its causes and treatments.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals with a genetically, enzymatically, or molecularly confirmed diagnosis of CDG or NGLY1 deficiency Exclusion Criteria: * None

What they're measuring

Indicators of Disease Severity and Progression - organ system involvement

Timeframe: Length of study, up to 5 years

Indicators of Disease Severity and Progression - degree of cognitive disability

Timeframe: Length of study, up to 5 years

Indicators of Disease Severity and Progression - case-fatality

Timeframe: Length of study, up to 5 years

Trial details

NCT IDNCT04199000

SponsorIcahn School of Medicine at Mount Sinai

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-07-31

Contact for this trial

Eva Morava-Kozicz, PhD, MD

(504) 444-9386 eva.morava@mssm.edu

View on ClinicalTrials.gov More Congenital Disorders of Glycosylation trials